ISRCTN10059974已完成2 期
A randomised phase II study of cytotoxic chemotherapy or cytotoxic chemotherapy combined with celecoxib or trastuzumab as primary chemotherapy for patients with high risk localised breast cancer not amenable to breast conserving therapy
Remagus (France)0 个研究点目标入组 340 人开始时间: 2007年2月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 340
研究概览
简要总结
- 2010 results on pre- and post- therapy detection of circulating tumor cells in http://www.ncbi.nlm.nih.gov/pubmed/19850639 2. 2010 main results in http://www.ncbi.nlm.nih.gov/pubmed/20480225 3. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21525400 4. 2019 results in http://www.ncbi.nlm.nih.gov/pubmed/30702971 [added 01/02/2019]
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Pathologically proven T1c-T4, N0-N1, M0 invasive breast cancer (Tumour, Nodes, Metastasis [TNM] classification)
- •2. No prior therapy
- •3. Age 18 to 65 years
- •4. Available frozen tumour tissue
- •5. Written informed consent
排除标准
- •1. Male patient
- •2. Prior therapy for breast cancer
- •3. Contraindication to study drug(s)
- •4. Stage IV breast cancer
研究者
相似试验
已完成
2 期
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin LymphomaLymphomaNCT01132807Alliance for Clinical Trials in Oncology164
终止
2 期
Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast CancerHER2-negative Metastatic Breast CancerNCT04720729Institut Curie160
Unknown
不适用
Cultured Circulating Tumor Cells in Prostate and Other CancersProstate CancerNCT02123862Oscar Goodman, Jr.220
已完成
不适用
Circulating Tumor Cells in Lung Cancer ScreeningLung NeoplasmsPulmonary Disease, Chronic ObstructiveNCT02500693Centre Hospitalier Universitaire de Nice683
已完成
2 期
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary SiteCarcinomaNCT00737243SCRI Development Innovations, LLC289